Sale!

ONCOLET 2.5

LETROZOLE TABLETS

MRP	:	~~MRP ₹74.34~~
Price	:	₹55.00
You Save	:	₹19.34 (26.02%)

10 tablet(s) in a strip

SKU: 212 Categories: Anti-Cancer, Anti-Cancer Drugs Tag: ANTI CANCER DRUGS Brand: Zydus Healthcare Limited

Oncolet 2.5mg is an anti-cancer drug classified as an aromatase inhibitor. Its primary use is as a supportive therapy after initial treatment, or as a first-line therapy, for postmenopausal women diagnosed with early or advanced breast cancer where the tumors are hormone receptor-positive.

The rationale behind its use is that high levels of estrogen are known to fuel the growth of certain breast cancers. Oncolet 2.5mg works by reducing the levels of this female reproductive hormone (estrogen). It achieves this by blocking the enzyme aromatase, which is crucial in the body’s production of estrogen. By lowering estrogen, the medicine aims to slow or halt the growth of breast cancer cells and/or prevent their spread to other parts of the body.

It is critical to inform your physician if you have not yet attained menopause, as this medicine is not effective for premenopausal women. Due to its action of reducing female reproductive hormone levels, it is not advised for menstruating women as it is associated with causing fertility issues. Patients taking this medicine are advised to monitor their cholesterol levels regularly, as Oncolet 2.5mg has a tendency to elevate them. Furthermore, Oncolet 2.5mg could also decrease bone mineral density. Therefore, discuss this with your physician and consider regular monitoring of your bone parameters. For women who are still able to conceive, it is strongly advised to use effective birth control throughout the duration of the treatment and for at least 3 weeks after the last dose

First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer.
Supportive to standard treatment for postmenopausal women with early breast cancer.
Treatment for unknown advanced breast cancer in postmenopausal women.
Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication

The growth of certain breast cancers is indeed stimulated by estrogens. Oncolet 2.5mg Tablet, which contains letrozole, is a nonsteroidal compound that specifically works by inhibiting estrogen production.

It achieves this by blocking the action of the enzyme called aromatase. Aromatase is responsible for converting other hormones (androgens) into estrogens, primarily in peripheral tissues like fat, muscle, and the liver, in postmenopausal women. By inhibiting this enzyme, Oncolet 2.5mg Tablet significantly reduces the levels of estrogen circulating in the body.

Since many breast cancer cells rely on estrogen for their growth and survival, this reduction in estrogen effectively reduces the tumor size and stops or slows the progression of the disease. This mechanism is crucial in avoiding the recurrence of early-stage breast cancer and ultimately improving the survival rate for affected individuals

It is crucial to have a comprehensive discussion with your doctor about all the medicines you are currently taking or have taken prior to starting treatment. This includes any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products. Providing this complete information is vital because certain medications can interact with Oncolet 2.5mg, potentially leading to undesirable side effects or affecting the medication's effectiveness. Your doctor needs this full picture to ensure your treatment is as safe and effective as possible.

It is crucial to consume the medicine exactly as your doctor prescribes. You can take Oncolet 2.5mg Tablet with or without food, and it should always be swallowed whole with a glass of water. For best results and to maintain consistent levels of the medication in your body, it is advisable to take the tablet at a fixed time each day. Remember, do not break, chew, or crush the tablet

keep the tablets away from the reach of children and pets.
Store Oncolet 2.5mg Tablets at an optimal temperature not exceeding 25°C.

Serious

Decreased red blood cells
Decreased bone mineral density
Fluid build up in lungs

Common:

Swelling in the face, eyes, feet, and legs
Hot sweats and excessive sweating
Hypercholesterolemia (high cholesterol)
Constipation
Heart palpilation
Hypertension
Diarrhea
Loss of appetite
Nausea and Vomiting
Muscle pain, bone pain, and joint stiffness
Dizziness, tiredness, and sleepiness
Breathing difficulty
Arthralgia

Breast Feeding

Unsafe

It is unsafe to breastfeed your baby when taking Oncolet 2.5mg tablet. It is advised to avoid breastfeeding for at least three weeks after the last dose of the medicine.

Alcohol

Unsafe

It is not recommended to consume alcohol while you are on the treatment with Oncolet 2.5mg tablet as it may cause serious complications.

Liver

Consult Your Doctor

Certain lung diseases can occur while using Oncolet 2.5mg tablet. Consult your doctor if you have lung disease.

Lungs

Consult Your Doctor

Inform your physician if you have liver disease, as the Oncolet 2.5mg tablet is not recommended for patients with severe liver disease. Dose adjustment may be required.

Driving

Unsafe

Caution is required while driving and operating machinery when you take Oncolet 2.5mg tablet causes dizziness, sleepiness, and tiredness.

Pregnancy

Unsafe

Oncolet 2.5mg tablet are highly unsafe during pregnancy because they may cause harm to the unborn baby. Discuss with your doctor about effective contraceptive methods. It is recommended to consult your physician if you are pregnant or may be pregnant.